Systemic mastocytosis is a rare, multisystem disorder with diverse clinical manifestations that can delay diagnosis and complicate management. This session reviews the cutaneous and systemic features of SM to support early recognition and appropriate diagnostic evaluation. Faculty will discuss current and emerging targeted therapies and their role in optimizing patient care. Attendees will gain practical strategies for coordinating multidisciplinary management to improve outcomes for patients with SM.
Learning Objectives
• Identify the cutaneous and systemic manifestations of SM using current guideline-based criteria to support appropriate initial evaluation and referral for systemic assessment
• Differentiate the mechanisms of action, efficacy, and safety of approved and emerging targeted therapies for SM
• Integrate multidisciplinary management strategies for patients with SM, including coordination across specialties and patient-centered, symptom-directed care
Supported by an educational grant from Blueprint Medicines Corporation.
